← All trials
NCT01091701
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2011
- Primary completion
- May 1, 2013
- Completion date
- May 1, 2013
- First posted
- —
- Last posted
- —
- Enrollment
- —
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Stempeutics Research Pvt LtdLead sponsor
- Hospital MelakaOverall official - principal investigator
- Hospital Raja Permaisuri BainunOverall official - principal investigator
- Hospital Sultanah BahiyahOverall official - principal investigator
- Hospital Sungai BulohOverall official - principal investigator
- KAUTERS HOSPITAL SEBERANG JAYAOverall official - principal investigator
- Stempeutics Research Malaysia SDN BHDCollaborator
- Hospital Kuala LumpurOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.